MoonLake Immunotherapeutics Stock Plummets After Phase 3 Data Readouts
MoonLake Immunotherapeutics Class A Ordinary Shares · PHARMACEUTICAL PREPARATIONS · Now $18.82
+17% in 7d after detection
Post-detection moves
1h
—
1d
+4.2%
3d
+11%
7d
+17%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS